Literature DB >> 33825825

Biosimilars in Dermatology.

Mark Lebwohl1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2021        PMID: 33825825     DOI: 10.1001/jamadermatol.2021.0219

Source DB:  PubMed          Journal:  JAMA Dermatol        ISSN: 2168-6068            Impact factor:   10.282


× No keyword cloud information.
  1 in total

1.  Switching from Adalimumab Originator to Biosimilar: Clinical Experience in Patients with Hidradenitis Suppurativa.

Authors:  Trinidad Montero-Vilchez; Carlos Cuenca-Barrales; Andrea Rodriguez-Tejero; Antonio Martinez-Lopez; Salvador Arias-Santiago; Alejandro Molina-Leyva
Journal:  J Clin Med       Date:  2022-02-15       Impact factor: 4.241

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.